ArticleBlood2018
Donor-derived MDS/AML in families with germline
Open access · bronzeAbstract readLetter
In one paragraph
Article in Blood, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.
- Monogenic etiologies of persistent human papillomavirus infections: A comprehensive systematic review.Genetics in medicine : official journal of the American College of Medical Genetics · 2024Pooled it
- Outcomes of germ line testing for children with hematologic malignancies undergoing hematopoietic cell transplantation.Blood advances · 2026Article
- Review
- Detecting likely germline variants during tumor-based molecular profiling.The Journal of clinical investigation · 2025Review
- A case report of donor cell-derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation.Oncotarget · 2025Article
- Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord blood.Annals of hematology · 2024Article
- Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment.Blood cancer discovery · 2024Review
- Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia.JCO precision oncology · 2024Article
- Genomic testing for germline predisposition to hematologic malignancies.Blood research · 2024Review
- Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.Transplantation and cellular therapy · 2024Review
- The different faces of GATA2 deficiency: implications for therapy and surveillance.Frontiers in oncology · 2024Article
- Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT.The Lancet. Haematology · 2023Review
- How I diagnose myeloid neoplasms with germline predisposition.American journal of clinical pathology · 2023Article
- A case of donor cell leukemia driven by a de novo NRAS mutation with complex karyotype.Annals of hematology · 2023Article
- The spectrum of GATA2 deficiency syndrome.Blood · 2023Article
- Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages.Blood · 2022Article
- Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.Current hematologic malignancy reports · 2022Review
- Article
- GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.British journal of haematology · 2022Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 9 institutions in 2 countries.
Pallavi GaleraHematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health (NIH), Bethesda, MD.
Amy P HsuLaboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD.ORCID 0000-0001-6841-2122
Weixin WangHematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health (NIH), Bethesda, MD.
Stephenie DrollHematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health (NIH), Bethesda, MD.
Rui ChenHematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health (NIH), Bethesda, MD.
Jason R SchwartzPathology Department, St. Jude Research Hospital, Memphis, TN.ORCID 0000-0002-1353-0508
Jeffery M KlcoPathology Department, St. Jude Research Hospital, Memphis, TN.
Sally AraiBlood and Marrow Transplant Program, Department of Medicine, Stanford University, Stanford, CA.
Luke MaesePediatric Hematology/Oncology, Primary Children's Medical Center, University of Utah, Salt Lake, City, UT.
Christa ZerbeLaboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD.
Mark J PartaClinical Research Directorate/Clinical Monitoring Research Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, MD; and.
Neal S YoungHematology Branch, National Heart Lung and Blood Institute, and.
Steven M HollandLaboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD.
Dennis D HicksteinExperimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, MD.
Katherine R CalvoHematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health (NIH), Bethesda, MD.ORCID 0000-0002-0771-4191
National Institutes of Health Clinical Center · USNational Institute of Allergy and Infectious Diseases · USSt. Jude Children's Research Hospital · USBeijing Tongren Hospital · CNFrederick National Laboratory for Cancer Research · USNational Cancer Institute · USNational Heart Lung and Blood Institute · USPrimary Children's Hospital · USStanford Blood Center · US
Funding
Pathogenesis And Treatment Of Aplastic AnemiaZIAHL002315 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI YOUNG, NEAL S · 2009 to 2025
$60.1MGenes And Gene Products As ImmunoadjuvantsZIAAI000647 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HOLLAND, STEVEN · 2009 to 2025
$22.6MTransgenic Animal Models Of Human Immune DefectsZIAAI000646 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HOLLAND, STEVEN · 2009 to 2025
$22.2MHematopoietic Stem Cell Transplant for Immunodeficiency with MDSZIABC010870 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HICKSTEIN, DENNIS · 2009 to 2025
$18.8MThe Role of microRNA in Hematologic MalignanciesZIACL090025 · CLC · CLINICAL CENTER · PI CALVO, KATHERINE · 2010 to 2025
$0kCCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001E
Abstract
PubMed holds no abstract for this paper.
Indexed as
Germ-Line MutationHematopoietic Stem Cell TransplantationAdolescentAdultFemaleGATA2 Transcription FactorHumansLeukemia, Myeloid, AcuteMaleMyelodysplastic SyndromesPedigreeTissue DonorsTreatment OutcomeYoung AdultGATA2 protein, humanGATA2 Transcription Factor
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.